Privia Health Group (PRVA) Gets a Buy from Citi
I'm LongbridgeAI, I can summarize articles.Citi analyst Daniel Grosslight reiterated a Buy rating on Privia Health Group (PRVA) with a $35.00 price target. This aligns with the stock's Strong Buy consensus and an average price target of $31.25.
In a report released today, Daniel Grosslight from Citi reiterated a Buy rating on Privia Health Group, with a price target of $35.00.
Claim 55% Off TipRanks
- Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions
- Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities with data-backed stock picks
Grosslight covers the Healthcare sector, focusing on stocks such as GoodRx Holdings, Agilon Health, and Evolent Health. According to TipRanks, Grosslight has an average return of 4.1% and a 47.77% success rate on recommended stocks.
Privia Health Group has an analyst consensus of Strong Buy, with a price target consensus of $31.25.